Sirona Biochem (CVE:SBM) Trading Up 4.5%

view original post

Sirona Biochem Corp. (CVE:SBMGet Rating)’s stock price was up 4.5% during mid-day trading on Monday . The stock traded as high as C$0.28 and last traded at C$0.23. Approximately 574,838 shares changed hands during trading, an increase of 707% from the average daily volume of 71,251 shares. The stock had previously closed at C$0.22.

The firm has a market cap of C$51.93 million and a P/E ratio of -13.75. The stock’s 50 day moving average is C$0.20 and its two-hundred day moving average is C$0.20. The company has a debt-to-equity ratio of 2,620.27, a current ratio of 0.95 and a quick ratio of 0.93.

About Sirona Biochem (CVE:SBM)

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.

Recommended Stories

Want More Great Investing Ideas?

Receive News & Ratings for Sirona Biochem Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Sirona Biochem and related companies with MarketBeat.com’s FREE daily email newsletter.